Picture of Taiko Pharmaceutical logo

4574 — Taiko Pharmaceutical News Story

0.000.00%
jp flag iconLast trade - 00:00
HealthcareAdventurousSmall CapNeutral

Table: Taiko Pharmaceutical -2023 parent results

Feb 9 (Reuters)- 
          Taiko Pharmaceutical Co Ltd 
          PARENT-ONLY FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)
                 Year ended       Year ended       Year to     NEXT     
              Dec 31, 2023     Dec 31, 2022   Dec 31, 2024     YEAR     
                 LATEST          YEAR-AGO        COMPANY      COMPANY   
                 RESULTS         RESULTS        FORECAST    H1 FORECAST 
  Sales           5.43             4.64                                 
               (+16.9 pct)                                              
  Operating     loss 1.04       loss 2.96                               
  Recurring     loss 1.33       loss 3.27                               
  Net           loss 3.72       loss 4.95                               
  EPS        loss 78.63 yen  loss 113.64 yen                            
  Ann Div          NIL             NIL                                  
  -Q2 Div          NIL             NIL                                  
  -Q4 Div          NIL             NIL                                  
  
  NOTE - Taiko Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4574.T

Recent news on Taiko Pharmaceutical

See all news